Search - tctmd.com

Displaying 1 - 20 of 91

Sort: Relevancy | Date

News Conference News TCT 2025

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

Yael L. Maxwell

October 28, 2025

News Conference News TCT 2025

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

Michael O'Riordan

October 28, 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

News Conference News CRT 2025

STEMI Revascularization Times All Over the Map: GWTG Registry

L.A. McKeown

March 14, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Conference News THT 2025

Experts Hash Out Recommendations for Impella CP After DanGer Shock

Todd Neale

February 14, 2025

News Conference News TCT 2024

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

Caitlin E. Cox

October 28, 2024

News Conference News EuroPCR 2024

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

Yael L. Maxwell

May 17, 2024

News Features

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Caitlin E. Cox

May 02, 2024

Presentation Fellows 2024

Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come

Presenter: David J. Cohen

April 12, 2024

News Daily News

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Michael O'Riordan

December 27, 2023

News Daily News

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

Caitlin E. Cox

June 21, 2023

News Conference News STS 2023

Large Medicare Analysis Reopens Debate Over Multivessel Revascularization

Yael L. Maxwell

January 24, 2023

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

News Conference News TCT 2022

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

L.A. McKeown

September 20, 2022

Presentation TCT 2022

Current Medical Therapy Is the Gold Standard for Plaque Stabilization

Presenter: David J. Cohen

September 18, 2022

News Daily News

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

Michael O'Riordan

September 15, 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Shelley Wood

September 07, 2022

News Daily News

Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

Caitlin E. Cox

July 20, 2022

Presentation Fellows 2022

The Evolution in PCI Pharmacology Over the Past 25 Years

Presenter: David Cohen

May 06, 2022

Advertisement

iFR-Guided Immediate PCI Not Superior to Deferred CMR-Guided Strategy in STEMI

STRIVE: Low-Dose Alteplase Ineffective in STEMI Patients With Large Thrombus

What’s Going to Be Hot at TCT 2025

STEMI Revascularization Times All Over the Map: GWTG Registry

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Experts Hash Out Recommendations for Impella CP After DanGer Shock

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

PCI for Multivessel Disease More Cost-effective Than CABG at 3 Years: FAME 3

After DanGer Shock’s Win in AMICS for Impella: What’s Next?

Reperfusion Therapies in Myocardial Infarction: How Far We’ve Come

Two ‘Evidence-Based Pathways’ for Stable Angina: ORBITA-2 Editorial

Medicare Data on AMICS Too Muddied for Firm Conclusions on Impella

Large Medicare Analysis Reopens Debate Over Multivessel Revascularization

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

FAVOR III China: Early Gains of QFR in PCI Persist to 2 Years

Current Medical Therapy Is the Gold Standard for Plaque Stabilization

COURAGE and ORBITA Had No Impact on Elective PCI Rates in UK

New Faces, New Formats, New Tech: What to Expect From TCT 2022

Longer-Term Data Still Worrisome for Impella-Treated AMICS Patients

The Evolution in PCI Pharmacology Over the Past 25 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content